规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
---|---|---|---|---|---|---|---|---|---|
00mg | ¥ ȕĒƘƍţţ | -- | -- | -- | -- | -- | -- | ¥ ȕĒƘƍţţ | - + |
250mg | ¥ ĨƣĒƍţţ | -- | -- | -- | -- | -- | -- | ¥ ĨƣĒƍţţ | - + |
g | ¥ ĠĒĨƍţţ | -- | -- | -- | -- | -- | -- | ¥ ĠĒĨƍţţ | - + |
5g | ¥ ȕƣȕżƍţţ | -- | -- | -- | -- | -- | -- | ¥ ȕƣȕżƍţţ | - + |
0g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
25g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
00g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
46.4
9
[]. Monia Brett P, et al. Antisense oligonucleotides for modulation of telomerase catalytic subunit gene expression and treatment of cancer. World Intellectual Property Organization, WO20008898 A. 200--22.
[2]. Reif B, et, al. Structural Comparison of Oligoribonucleotides and Their 2′-Deoxy-2′-fluoro Analogs by heteronuclear NMR spectroscopy. Helvetica Chimica Acta. 997 Jou; 80(6): 952-97.
[3]. Zhang Hongyan, et al. Combined drug for treating hepatitis B and its application in preparing drugs for preventing and/or treating HBV (hepatitis B virus)-induced symptom or diseases. China, CN007040 A. 2020--0.
H35-H37-H39-H335-H360
P26-P264-P270-P27-P280-P302+P352-P304+P340-P305+P35+P338-P330-P362+P364-P403+P233-P405-P50